Soft tissue sarcoma exhibits the highest mutation rate (>30%) for HDAC4, while non-small cell lung cancer and melanoma have the second highest frequency of HDAC4 gene alterations (15-17%)28. This evidence concerns the gene HDAC4 and non-small cell lung carcinoma.